[HTML][HTML] A general platform for targeting MHC-II antigens via a single loop

H Du, J Liu, KM Jude, X Yang, Y Li, B Bell, H Yang… - bioRxiv, 2024 - ncbi.nlm.nih.gov
Class-II major histocompatibility complexes (MHC-IIs) are central to the communications
between CD4+ T cells and antigen presenting cells (APCs), but intrinsic structural features …

[HTML][HTML] Decoupling peptide binding from T cell receptor recognition with engineered chimeric MHC-I molecules

GF Papadaki, O Ani, TJ Florio, MC Young… - Frontiers in …, 2023 - frontiersin.org
Major Histocompatibility Complex class I (MHC-I) molecules display self, viral or aberrant
epitopic peptides to T cell receptors (TCRs), which employ interactions between …

PANDORA: a fast, anchor-restrained modelling protocol for peptide: MHC complexes

FM Parizi, DF Marzella, DV Tilborg, N Renaud… - bioRxiv, 2022 - biorxiv.org
Deeper understanding T-cell mediated adaptive immune responses bears important
implications in designing cancer immunotherapies and antiviral vaccines against pandemic …

[HTML][HTML] Variations in MHC class I antigen presentation and immunopeptidome selection pathways

AJ Zaitouna, A Kaur, M Raghavan - F1000Research, 2020 - ncbi.nlm.nih.gov
Major histocompatibility class I (MHC-I) proteins mediate immunosurveillance against
pathogens and cancers by presenting antigenic or mutated peptides to antigen receptors of …

Structure modeling and specificity of peptide-MHC class I interactions using geometric deep learning

A Aronson, T Hochner, T Cohen… - bioRxiv, 2022 - biorxiv.org
Abstract Major Histocompatibility Complex (MHC) plays a major role in the adaptive immune
response by recognizing foreign proteins through binding to their peptides. In humans alone …

[HTML][HTML] Re-Directing CD4+ T Cell Responses with the Flanking Residues of MHC Class II-Bound Peptides: The Core is Not Enough

CJ Holland, DK Cole, A Godkin - Frontiers in immunology, 2013 - frontiersin.org
Recombinant αβ T cell receptors, expressed on T cell membranes, recognize short peptides
presented at the cell surface in complex with MHC molecules. There are two main subsets of …

The optimization of bioorthogonal epitope ligation within MHC-I complexes

JB Pawlak, BJ Hos, MJ van de Graaff… - ACS chemical …, 2016 - ACS Publications
Antigen recognition followed by the activation of cytotoxic T-cells (CTLs) is a key step in
adaptive immunity, resulting in clearance of viruses and cancers. The repertoire of peptides …

[HTML][HTML] Computationally profiling peptide: MHC recognition by T-cell receptors and T-cell receptor-mimetic antibodies

MIJ Raybould, DA Nissley, S Kumar… - Frontiers in …, 2023 - frontiersin.org
T-cell receptor-mimetic antibodies (TCRms) targeting disease-associated peptides
presented by Major Histocompatibility Complexes (pMHCs) are set to become a major new …

[HTML][HTML] Genome-wide structural modelling of TCR-pMHC interactions

IH Liu, YS Lo, JM Yang - BMC genomics, 2013 - Springer
Background The adaptive immune response is antigen-specific and triggered by pathogen
recognition through T cells. Although the interactions and mechanisms of TCR-peptide-MHC …

[HTML][HTML] Minimal conformational plasticity enables TCR cross-reactivity to different MHC class II heterodimers

CJ Holland, PJ Rizkallah, S Vollers, JM Calvo-Calle… - Scientific reports, 2012 - nature.com
Successful immunity requires that a limited pool of αβ T-cell receptors (TCRs) provide cover
for a vast number of potential foreign peptide antigens presented by 'self'major …